日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A SARS-CoV-2 EG.5 mRNA vaccine induces a broad-spectrum immune response in mice

SARS-CoV-2 EG.5 mRNA疫苗可在小鼠体内诱导广谱免疫反应。

Wang, Hongyu; Peng, Qinhua; Dai, Xinxian; Ying, Zhifang; Wu, Xiaohong; Liu, Xinyu; Xu, Hongshan; Li, Jia; Shi, Leitai; Liu, Jingjing; Wang, Yunpeng; Zhao, Danhua; Huang, Yanqiu; Yang, Lihong; Yang, Ren; Yue, Guangzhi; Suo, Yue; Ye, Qiang; Cao, Shouchun; Li, Yuhua

Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccines

先后接种Sabin株灭活脊髓灰质炎疫苗和口服减毒脊髓灰质炎疫苗后脊髓灰质炎病毒的排出情况

Fu, Yuting; Ma, Rufei; Zhao, Zhimei; Mo, Zhaojun; Ying, Zhifang; Li, Jing; Ye, Hui; Li, Guoliang; Liu, Xiaochang; Liang, Jiangli; Ping, Ling; Li, Jingyan; Tao, Junhui; Yang, Qinghai; Wei, Dingkai; Yi, Li; Chen, Hongbo; Wang, Jianfeng; Jiang, Ruiju; Yu, Lei; Cai, Wei; Yang, Wei; Yue, Lei; Xie, Mingxue; Yin, Qiongzhou; Pu, Jing; Hong, Chao; Cai, Lukui; Deng, Yan; Wen, Jiana; Ma, Yan; Gao, Na; Wang, Xiaoyu; Liao, Hongwei; Ji, Qiuyan; Ji, Guang; Hu, Wenzhu; Gu, Qin; He, Xiaoyue; Chu, Han; Fu, Yixian; Zhou, Jian; Wen, Yu; Yang, Xiaolei; Li, Changgui; Shi, Li; Zhao, Ting; Huang, Teng; Yang, Jingsi

Safety and Immunogenicity of sIPV in Healthy Infants Aged 2 Months Following Sequential Immunization Program Combination with bOPV: A Phase 3, Randomized, Blinded, Parallel Positive-Controlled Clinical Trial

sIPV联合bOPV对2月龄健康婴儿序贯免疫接种计划后的安全性和免疫原性:一项3期随机、双盲、平行阳性对照临床试验

Liu, Yafei; Liu, Xiaodong; Zhang, Li; Chang, Xianyun; Xiong, Ping; Guan, Yanxin; Li, Yixin; Zhang, Weiling; Xuan, Lili; Li, Yan; Ying, Zhifang; Xu, Qing

Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial

广谱抗SARS-CoV-2单克隆抗体SA55鼻喷雾剂在健康志愿者中的安全性和鼻内滞留性:一项I期临床试验

Hu, Chaoying; Zhou, Yibo; Meng, Xing; Li, Jianhua; Chen, Jinxia; Ying, Zhifang; Xie, Xiaoliang Sunney; Hu, Yaling; Cao, Yunlong; Jin, Ronghua

A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China

一项在中国开展的3期随机、开放标签研究,旨在评估同时接种五价轮状病毒活疫苗和灭活脊髓灰质炎疫苗以及分期接种对健康婴儿的免疫原性和安全性。

Chen, Shaomin; Ying, Zhifang; Liu, Yan; Li, Yuan; Yu, Yebin; Huang, Meilian; Huang, Zhuhang; Ou, Zhiqiang; Liao, Yuyi; Zhang, Yong; Liu, Guixiu; Zhao, Weiwei; Fu, Rong; Shou, Qiong; Zheng, Minghuan; Liao, Xueyan; Tu, Yingmei; Stek, Jon; Hartzel, Jonathan; Li, Changgui; Zhang, Jikai

Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial

灭活新冠疫苗(CoronaVac®)与灭活肠道病毒71型疫苗(Inlive®)联合接种的免疫原性和安全性:一项4期随机对照试验

Shu, Yajun; Sun, Zhuoqun; Gao, Fan; Huang, Zhuhang; Meng, Xing; Chen, Shaomin; Shu, Qun; Wang, Lianhao; Zhang, Hengming; Ying, Zhifang; Zhang, Jikai

Quantitative Analysis of the Instant and Persistent Inhibition Effects of Maternal Poliovirus Antibodies on the Immune Response in a Phase IV Trial of a Sabin Strain-Based Inactivated Poliovirus Vaccine

母体脊髓灰质炎病毒抗体对基于Sabin毒株的灭活脊髓灰质炎疫苗IV期临床试验中免疫反应的即时和持久抑制作用的定量分析

Yin, Qiongzhou; Zheng, Yan; Ying, Zhifang; Li, Jingyu; Jiang, Ya; Bao, Wenmei; Dou, Youjian; Pu, Yi; Lei, Jin; Yang, Haitao; Jiang, Ruiju; Deng, Yan; Zhao, Zhimei; Pu, Jing; Yang, Jing; Li, Yadong; Xu, Min; Cai, Wei; Che, Yanchun; Shi, Li

Immune persistence of an inactivated poliovirus vaccine derived from the Sabin strain: a 10-year follow-up of a phase 3 study

源自萨宾株的灭活脊髓灰质炎疫苗的免疫持久性:一项3期研究的10年随访

Ma, Lei; Ying, Zhifang; Cai, Wei; Wang, Jianfeng; Zhou, Jian; Yang, Huijuan; Gao, Jingxia; Zhao, Zhimei; Liu, Jing; Ouyang, Shengjie; Song, Shaohui; Shen, Fei; Zhao, Ruirui; Xu, Lilan; Dai, Xiaohu; Wu, Yanan; Li, Weidong; Li, Changgui; Liao, Guoyang

Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial

在中国3-17岁健康儿童和青少年中评估一种蛋白亚单位COVID-19疫苗(ZF2001)的安全性和免疫原性:一项随机、双盲、安慰剂对照的I期临床试验和一项开放标签、非随机、非劣效性的II期临床试验

Gao, Lidong; Li, Yan; He, Peng; Chen, Zhen; Yang, Huaiyu; Li, Fangjun; Zhang, Siyuan; Wang, Danni; Wang, Guangyan; Yang, Shilong; Gong, Lihui; Ding, Fan; Ling, Mengyu; Wang, Xilu; Ci, Leilei; Dai, Lianpan; Gao, George Fu; Huang, Tao; Hu, Zhongyu; Ying, Zhifang; Sun, Jiufeng; Zuo, Xiaohu

The impact of different IPV-OPV sequential immunization programs on hepatitis A and hepatitis B vaccine efficacy

不同IPV-OPV序贯免疫方案对甲型肝炎和乙型肝炎疫苗效力的影响

Chen, Shiyi; Zhao, Yuping; Yang, Zhiyao; Li, Ying; Shi, Hongyuan; Zhao, Ting; Yang, Xiaolei; Li, Jing; Li, Guoliang; Wang, Jianfeng; Ying, Zhifang; Yang, Jingsi